Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Wheeler

Showing results (351-360 of 455) with videos related to

Pageof 46
Sort By:
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
The New England Journal of Medicine|November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis, Glenn M Chertow, Geoffrey A Block, et al.
Kidney International|September 24, 2019
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceThomas H Marwick, Kerstin Amann, Sripal Bangalore, et al.
Kidney International|April 17, 2018
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKai-Uwe Eckardt, Nisha Bansal, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association|November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trialDavid C Wheeler, Gerard M London, Patrick S Parfrey, et al.
BMJ Open|April 22, 2018
Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview studyAllison Tong, Sally Crowe, John S Gill, et al.
Journal of the American Society of Nephrology : JASN|June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKDAnthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
The Annals of Occupational Hygiene|January 7, 2016
Combining Decision Rules from Classification Tree Models and Expert Assessment to Estimate Occupational Exposure to Diesel Exhaust for a Case-Control StudyMelissa C Friesen, David C Wheeler, Roel Vermeulen, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.
Pageof 46

Showing results (351-360 of 455) with videos related to

Sort By:
Pageof 46
European Journal of Heart Failure|May 20, 2025
Recurrent event analyses in patients receiving maintenance dialysis and the effect of higher- versus lower-dose chronic intravenous iron therapy: A report focusing on heart failure events from the PIVOTAL trialStefan D Anker, Michele Robertson, John J V McMurray, et al.
The New England Journal of Medicine|November 6, 2012
Effect of cinacalcet on cardiovascular disease in patients undergoing dialysis, Glenn M Chertow, Geoffrey A Block, et al.
Kidney International|September 24, 2019
Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceThomas H Marwick, Kerstin Amann, Sripal Bangalore, et al.
Kidney International|April 17, 2018
Improving the prognosis of patients with severely decreased glomerular filtration rate (CKD G4+): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies ConferenceKai-Uwe Eckardt, Nisha Bansal, Josef Coresh, et al.
Journal of the American Society of Nephrology : JASN|October 25, 2023
Effect of SGLT2 Inhibitors on Discontinuation of Renin-angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD TrialsRobert A Fletcher, Niels Jongs, Glenn M Chertow, et al.
Journal of the American Heart Association|November 19, 2014
Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trialDavid C Wheeler, Gerard M London, Patrick S Parfrey, et al.
BMJ Open|April 22, 2018
Clinicians' and researchers' perspectives on establishing and implementing core outcomes in haemodialysis: semistructured interview studyAllison Tong, Sally Crowe, John S Gill, et al.
Journal of the American Society of Nephrology : JASN|June 20, 2025
Biomarkers of Kidney Failure and All-Cause Mortality in CKDAnthony Onoja, Thomas McDonnell, Isabelle Annessi, et al.
The Annals of Occupational Hygiene|January 7, 2016
Combining Decision Rules from Classification Tree Models and Expert Assessment to Estimate Occupational Exposure to Diesel Exhaust for a Case-Control StudyMelissa C Friesen, David C Wheeler, Roel Vermeulen, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|November 14, 2015
Cinacalcet, dialysate calcium concentration, and cardiovascular events in the EVOLVE trialPatrick H Pun, Safa Abdalla, Geoffrey A Block, et al.
Pageof 46